The roots of C. crassifolius has been used in folk and traditional Chinese medicine for treatment of stomachache, sore throat, and rheumatism. 8 In Thailand, it is used by indigenous people for treatment of cancer. 9 Previous chemical investigation on C. crassifolius revealed that the main constituents were sesquiterpoids and bicyclic diterpenoids.
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As part of our continuing studies on the constituents of the traditional herbal medicines, 14, 15 the present paper deals with the isolation and structural elucidation of a new halimane diterpenoid, named crassifoliusin A (1), along with a known halimane diterpenoid, chettaphanin I (2), 9, 16 from the 95% aqueous EtOH extract of the roots of C. crassifolius. The cytotoxicity of compound 1 was evaluated against HepG2, SGC-7901, and K562 cell lines.
Compound 1 was obtained as yellow crystals from acetone and exhibited a quasi-molecular ion peak at m/z 357. 13 C-NMR and DEPT spectra of 1 showed 21 carbon signals, of which 20 were from the diterpene skeleton and one from the esterified methyl group. Signals for a β-substituted furan ring at δ C 142.8 (C-16), 142.5 (C-15), 119.5 (C-13), and 110.1 (C-14) were observed. Other salient features of these spectra include signals assigned to an α,β-unsaturated ketone group at δ C 193.8 (C-2), an ester carbonyl group at δ C 175.6 (C-18), one tertrasubstituted double bond group at δ C 132.3 (C-1), and 170.4 (C-10), one trisubstituted double bond group at δ C 142.3 (C-11), and 130.2 (C-12), one oxygenated quaternary carbon at δ C 75.8 (C-5). The remaining signals were due to three methyls, three methylenes, one methines, two quarternary carbons ( Table 1) . The 
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H COSY spectrum of 1 enabled extensive systems to be declineated. Vicinal (6) . In the HMBC experiment, long-range correlations between the following protons and carbons were observed: H 3 -19 and C-3, C-4, C-5, C-18; H 2 -3 and C-1, C-2, C-4, C-5, C-18; H 2 -6 and C-4, C-5, C-7, C-8, C-10; H 3 -17 and C-7, C-8, C-9; H 3 -20 and C-8, C-9, C-10, C-11; H-15 and C-13, C-14, C-16. These spectral data suggested the presence of a halimane diterpenoid skeleton with a β-substituted furan ring in 1. The 13 C-NMR spectrum was similar to chettaphanin I (2), 9, 16 except for the lack of a C-12 keto carbonyl group, instead of the presence of olefinic carbons at 142.3 (C-11), and 130.2 (C-12). The HMBC spectrum also showed correlations between H-11 and C-1, C-8, C-9, C-10, suggested that the presence of a cyclopentadiene ring formed by C-9, C-10, C-1, C-12 and C-11 in 1.
The relative configuration of 1 was established by analysis of NOEs detected in difference NOE experiments and X-ray crystallographic diffraction. Difference NOE experiment irradiating H 3 -17 enhanced the intensity of H 3 -20. Additionally, irradiation of H 3 -19 enhanced the intensities of OH-5 and H-3α (δ H 2.69). Therefore, H 3 -17 and H 3 -20, OH-5, H 3 -19 and H-3α should have a cis relationship, respectively. The structure and relative configuration of 1 were finally confirmed by a single-crystal X-ray diffraction (Fig. 3) . Thus, compound 1 was assigned as 5α-hydroxy-15,16-epoxy-2-oxo-halima-1(10),11,13(16),14-tetraene-18-oic acid methyl ester, and named crassifoliusin A.
In addition, one known compound was isolated. By comparing its NMR spectroscopic data with those in the literature, its structure was determined to be chettaphanin I (2) 9, 16 ( Fig. 1) .
The new compound 1 was tested for its cytotoxicity against three human cancer cell lines (HepG2, SGC-7901, and K562) using MTT method with Doxorubicin as the positive control. It showed no cytotoxicity against tested cell lines (IC 50 > 50 μg/mL).
Experimental Section
General Experimental Procedures. Melting points were determined on an X-4 digital display micromelting point apparatus, and are uncorrected. UV spectra were recorded on a Shimadzu UV-2550 UV-Vis spectrophotometer. Optical rotations were measured on a Perkin Elmer 341 polarimeter. IR spectra were taken on a Nicolet NEXUS 670 FT-IR spectrometer. NMR spectra were recorded on a Varian Mercury-600BB NMR spectrometers with TMS as internal standard. HR-ESI-MS data were recorded on a Thermo LTQ Orbitrap Elite mass spectrometer. Sephadex LH-20 were supplied by Amersham Pharmacia Biotech. Silica gel (200-300 mesh) used for column chromatography and silica gel GF 254 (10-40 μM) used for TLC were supplied by the Qingdao Marine Chemical Factory, Qingdao, China. Spots were detected on TLC under UV light or by heating after spraying with 5% H 2 SO 4 in C 2 H 5 OH (v/v).
Plant Material. The roots of C. crassifolius were purchased from Hebei Anguo Medicine Market, and were originally collected from Fujian province of China in September 2012. A voucher specimen (No. 201209CC) was deposited at the School of Pharmacy, Lanzhou University and was identified by Dr. Jian-Yin Li.
Extraction and Isolation. The air-dried and powdered roots of C. crassifolius (9.5 kg) were extracted four times with 95% aqueous EtOH at room temperature to give a residue (962 g) after evaporation. The residue was suspended in H 2 O and extract with EtOAc and n-BuOH. The EtOAc partition (731 g) was applied to silica gel CC, eluting with petroleum ether-acetone (40:1-0:1 gradient system). Then o , of which 2108 unique reflections with I > 2σ (I) were collected for the analysis. The structure was solved by direct methods using SHELXS97 and refined by full matrix leastsquares on F
2
. The final R and R W factors were 0.060 and 0.128, respectively.
